[Electrophoretic study of the cerebrospinal fluid proteins in multiple sclerosis. II. Influence of immunosuppressive chemotherapy].
作者信息
Castaigne P, Lhermitte F, Schuller E, Rouques C, Loridan M
出版信息
Rev Eur Etud Clin Biol. 1971 Aug-Sep;16(7):703-6.
PMID:4107372
Abstract
摘要
相似文献
1
[Electrophoretic study of the cerebrospinal fluid proteins in multiple sclerosis. II. Influence of immunosuppressive chemotherapy].[多发性硬化症患者脑脊液蛋白质的电泳研究。II. 免疫抑制化疗的影响]
Rev Eur Etud Clin Biol. 1971 Aug-Sep;16(7):703-6.
2
[Electrophoretic study of cerebrospinal fluid proteins in multiple sclerosis. Clinical, biological and therapeutic correlations].[多发性硬化症患者脑脊液蛋白质的电泳研究。临床、生物学及治疗相关性]
Rev Neurol (Paris). 1971 Feb;124(2):97-105.
3
[Electrophoretic study of cerebrospinal fluid proteins during multiple sclerosis: 1) research on biochemical, cytological and clinical correlations].多发性硬化症患者脑脊液蛋白质的电泳研究：1）生化、细胞学及临床相关性研究
Rev Eur Etud Clin Biol. 1971 Jun-Jul;16(6):610-5.
4
Multiple sclerosis. CNS electrophoretic patterns as aid in diagnosis.多发性硬化症。中枢神经系统电泳图谱对诊断的辅助作用。
J Kans Med Soc. 1973 Mar;74(3):87-90.
5
[Effects of prednisone and azathioprine treatment on oligoclonal IGG in the cerebrospinal fluid of multiple sclerosis patients. Preliminary communication].
Neurol Neurochir Pol. 1996 Mar-Apr;30(2):201-11.
6
7
[Electrophoretic and immunoelectrophoretic studies in multiple sclerosis].[多发性硬化症的电泳和免疫电泳研究]
Neurol Psihiatr Neurochir. 1972 Mar-Apr;17(2):169-78.
8
[Importance and significance of electrophoretic changes in serum and cerebrospinal-fluid proteins in multiple sclerosis].[多发性硬化症患者血清和脑脊液蛋白质电泳变化的重要性及意义]
Stud Cercet Neurol. 1970;15(4):231-8.
9
[Changes in cerebrospinal fluid proteins in polyneuritis].[多发性神经炎时脑脊液蛋白质的变化]
Schweiz Med Wochenschr. 1972 Jun 3;102(22):766-72.
10
[Comparative value of visual evoked potentials with the study of cerebrospinal fluid in the diagnosis of multiple sclerosis--apropos of 43 cases].[视觉诱发电位与脑脊液检查在多发性硬化症诊断中的比较价值——附43例报告]
Bull Soc Ophtalmol Fr. 1983 May;83(5):725-6, 729.
引用本文的文献
1
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
J Neurol. 1977 Feb 17;214(3):173-81. doi: 10.1007/BF00316148.
Zotero 插件